Navigation Links
Qforma Appoints Kent Harris as Senior Vice President of Sales
Date:12/4/2008

SANTA FE, N.M., Dec. 4 /PRNewswire/ --Qforma, an advanced analytics and predictive modeling company, today announced the appointment of Kent Harris as Senior Vice President of Sales, New Business.

"Kent is highly regarded in the pharmaceutical industry and is an ideal addition to Qforma's commercial team," stated Kelly D. Myers, CEO of Qforma. "He brings nearly two decades of industry experience and an impressive record of measurable results. His success in sales operations across therapeutic areas will be a strong asset to our clients."

Harris joined Qforma from Organon Pharmaceuticals (now Schering-Plough), where he was responsible for leading a sales region comprised of 125 representatives and 11 district managers that generated $80 million in annual revenue. In his seven years as a Regional Director at Organon Pharmaceuticals, his teams consistently finished in the top 20 percent of the company.

Harris began his career with the Upjohn Company as a Sales Representative in Longview, Texas. His success in pharmaceutical field sales resulted in a promotion and a transfer to the Upjohn headquarters in Kalamazoo, MI, where he worked as a Senior Market Analyst responsible for field sales force size and structure in the U.S. and Puerto Rico. Harris was subsequently promoted to District Sales Manager, where he led a district comprised of 15 specialty representatives promoting over 25 products. He also worked for MEDai, a provider profiling company in Orlando, FL, which serviced national healthcare organizations including payers and providers, pharmaceutical companies, pharmacy benefit management and disease management companies.

"Kent's depth of knowledge in both the pharmaceutical and healthcare industries will be of great benefit to our customers and partners who will be looking for new directions and solutions in 2009," said Al Reicheg, Qforma's Senior Vice President of C
'/>"/>

SOURCE Qforma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Novo Nordisk Appoints New Leader of North American Business
4. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. Resonant Medical Appoints New Vice President of Global Sales
7. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
8. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
9. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
10. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
11. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... (PRWEB) November 18, 2014 Hawthorne cosmetic ... affordable for patients. Nearly 70 percent of Americans over the ... the age of 74, 25 percent are missing not just ... options are available, but only one offers a look, feel, ... , This special includes a complimentary consultation that allows patients ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Driving "bad" LDL cholesterol down to extremely low levels ... attacks and strokes in high-risk patients with clogged arteries, ... attacks and strokes when taking Vytorin, a drug that ... medication called ezetimibe, said principal investigator Dr. Christopher Cannon, ...
(Date:11/18/2014)... By Dennis Thompson ... (HealthDay News) -- An experimental antibody drug could prove ... who have side effects with cholesterol-lowering statin medications. ... at the American Heart Association annual meeting in Chicago. ... is currently the most widely used alternative to statins, ...
(Date:11/18/2014)... TUESDAY, Nov. 18, 2014 (HealthDay News) -- Cocaine users ... is hard to detect, which can put them at ... study warns. Researchers in Chicago compared heart imaging ... who didn,t use the illegal drug. Those using ... heart,s smallest blood vessels, which were considered significant when ...
(Date:11/18/2014)... November 18, 2014 Recently, BellasDress has announced ... Made by qualified workers and using comfortable fabrics, the new ... is carrying a variety of wonderful holiday gifts in a ... welcome these new prom dresses, and they are created by ... collection is an absolutely great addition to our sales team ...
Breaking Medicine News(10 mins):Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 2Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 3Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Cocaine Can Cause Heart Problems: Study 2Health News:85 New Models Of White Prom Dresses From BellasDress.com Online For Sale 2
... Previous studies have shown inhaled corticosteroids can decrease ... say long-term use of ICS therapy is not ... ,Corticosteroids are commonly used to treat asthmatics and ... these medications are good at reducing inflammation and ...
... are creating a whole new experience for patients in ... putting more smiles on their patients' faces.// ,Laser ... tissue removal, less bleeding and less discomfort for patients. ... Some diagnose cavities, while others remove gum and tooth ...
... of rickets as a disease of the past. New ... and prevention should start before birth and researchers suggest ... ,Rickets is a childhood disorder involving softening and weakening ... D, calcium, or phosphate. It is most likely to ...
... new and simple test could be a major improvement for ... to assess a patient's response to HIV medication.// ,HIV ... now becoming available in Africa. While on the medication, tests ... CD4 cell count indicates a need for more intensive treatment ...
... breast cancer patients who receive radiation therapy after ... more likely to develop complications.// However, a new ... ,Researchers from the Fox Chase Cancer Center ... a mastectomy, breast reconstruction, and postoperative radiation between ...
... combination treatment looks like a better option for some ... the size of the tumor //before using lasers to ... the combination treatment improves the overall survival of the ... (LITT) to heat tumors. The problem is the tumor ...
Cached Medicine News:Health News:New Liver Tumor Treatment 2
(Date:11/17/2014)...  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) ... 2013 collaboration, option, and license agreement to co-develop INO-5150, ... their research collaboration in prostate cancer. All of Roche,s ... product to other parties, will be returned to Inovio.  ... I clinical trial in the first half of 2015. ...
(Date:11/16/2014)...  Hanger, Inc. (NYSE: HGR ) announced ... third quarter 2014 financial results and is cancelling its ... for the completion and review of its third quarter ... financial results and reschedule its conference call after the ... About Hanger, Inc. – Built on the ...
(Date:11/16/2014)... 2014 Die führenden ... Zugang zur medizinischen Versorgung in Entwicklungsländern durch ... Innovationen in den letzten beiden Jahren zu ... einigen wesentlichen Bereichen schwer damit, gute Ergebnisse ... "2014 Access to Medicine Index". ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 2Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 4Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 5Pharmaindustrie unternimmt mehr zur Verbesserung des Zugangs zur medizinischen Versorgung in Entwicklungsländern. Leistungen hinken in manchen Bereichen hinterher 2Pharmaindustrie unternimmt mehr zur Verbesserung des Zugangs zur medizinischen Versorgung in Entwicklungsländern. Leistungen hinken in manchen Bereichen hinterher 3Pharmaindustrie unternimmt mehr zur Verbesserung des Zugangs zur medizinischen Versorgung in Entwicklungsländern. Leistungen hinken in manchen Bereichen hinterher 4Pharmaindustrie unternimmt mehr zur Verbesserung des Zugangs zur medizinischen Versorgung in Entwicklungsländern. Leistungen hinken in manchen Bereichen hinterher 5
... 15, 2012  National data center hosting ... and healthcare technology consulting firm, Burwood Group Inc., ... presentation at the 2012 Annual HIMSS Conference & ... and the importance of disaster recovery planning ...
... 2012 Anlit Advanced Nutrition Supplements , ... supplements for children, will start selling its products ... Anlit will distribute its wide variety of supplements for ... leading local producer of natural healing products. Laboratoria Natury was ...
Cached Medicine Technology:National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012 2National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012 3National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012 4Anlit Enters Polish Market with New Food Supplements for Kids 2
... Addressing the key clinical and economic issues ... System is designed to maximize tension control ... The system combines efficient instrumentation with a ... Grip system is indicated for general orthopaedic ...
... worlds first multi-filament orthopaedic cable, Dall-Miles™, ... a means of providing superior fixation ... procedures. Today, with more than 100 ... the Dall-Miles™ Cable System continues to ...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery....
... have become the accepted standard for,excellence and ... AML Total Hip System was the first ... meet the needs for biological fixation in ... 15 years of documented clinical performance, the ...
Medicine Products: